Research Year in Review
Speaker: Lisa Murtha
- Relevant new laws, regulations, and guidance from federal and state government agencies on the conduct of research
- New OIG Workplan and its research initiatives as well as key enforcement initiatives and settlements related to research
- Novel approaches to addressing these new government initiatives within research compliance programs
Presentation
Evaluation
|
|
Compliance with Psychedelics and Emerging Therapies
Speakers: Debbie Casey, Kelly Willenberg, Linda Iovanni
- Discussion of emerging therapies including clinical trials and the future of psychotherapy
- Discussion of steps that can be taken to mitigate risk and increase protective factors for the subjects
- Review of integration techniques, resources, legal and ethical issues with these emerging therapies
Presentation
Evaluation
|
|
Why DEI Initiatives in Research are Not Working: Time for a Deeper Dive!
Speaker: Quincy Byrdsong
- Define current and recent trends in DEI in research and associated precipitating influences
- Dispel myths and address barriers to DEI initiatives leading to concrete gains
- Transfer the overwhelming energy on identifying problems to generating solutions
Presentation
Evaluation
|
|
Enforcement Issues in Drug and Device Research
Speaker: Clint Narver
- Overview of research misconduct in drug and device development
- Discussion of federal enforcement efforts
- Best practices for ensuring research integrity and compliance
Presentation
Evaluation
|
|
Research Security Updates
Speaker: Kristen West
- Status of research security program standards and disclosure requirements
- How are funding agencies reviewing and using information that is disclosed?
- Steps institutions should be taking to develop compliance strategies
Presentation
Evaluation
|
|
Compliance Considerations for Decentralized Clinical Trials
Speaker: Adam Samson
- Ethics & equity
- Technology adoption & implementation
- Control design for decentralization
Presentation
Evaluation
|
